Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vancomycin population pharmacokinetics during CVVH in critically ill patients
ChiCTR-OPC-17012979Phase 4Not yet recruiting
- Sponsor
- Peking University Third Hospital
- Start
- Jan 2018
- Modality
- Antimicrobial Peptides → Native Peptides → Peptides, Cyclic Peptides → Modified Peptides → Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of vancomycin in Infection (2 arms), sponsored by Peking University Third Hospital. Primary endpoint: Plasma concentration of vancomycin. Planned start Jan 2018; status: not yet recruiting.
02
Drugs
vancomycin
03
Conditions
Infection
Beyond the preview
Go deeper on ChiCTR-OPC-17012979.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPC-17012979.